HIV-1 Membrane Fusion

The AIDS pandemic is spreading unchecked in many parts of the world. Currently available anti-viral regimens are plagued by their high cost, by serious side effects in a significant minority of recipients, and by the increasing problems of drug-resistant HIV variants. Fortunately, rapid advances in

[1]  G. Melikyan,et al.  Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion , 2000, The Journal of cell biology.

[2]  R. T. Armstrong,et al.  The Transmembrane Domain of Influenza Hemagglutinin Exhibits a Stringent Length Requirement to Support the Hemifusion to Fusion Transition , 2000, The Journal of cell biology.

[3]  Misuzu Baba,et al.  Geranylgeranylated Snares Are Dominant Inhibitors of Membrane Fusion , 2000, The Journal of cell biology.

[4]  J. Rothman,et al.  Close Is Not Enough , 2000, The Journal of cell biology.

[5]  S. Zolla-Pazner,et al.  Recognition by Human Monoclonal Antibodies of Free and Complexed Peptides Representing the Prefusogenic and Fusogenic Forms of Human Immunodeficiency Virus Type 1 gp41 , 2000, Journal of Virology.

[6]  J. Skehel,et al.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  F S Cohen,et al.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. , 1999, Molecular biology of the cell.

[8]  Q. Sattentau,et al.  The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. , 1999, AIDS.

[9]  J. Skehel,et al.  Coiled Coils in Both Intracellular Vesicle and Viral Membrane Fusion , 1998, Cell.

[10]  Eric Hunter,et al.  Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.

[11]  Ying Sun,et al.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. , 1998, Science.

[12]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[13]  P. S. Kim,et al.  HIV Entry and Its Inhibition , 1998, Cell.

[14]  C. Weiss,et al.  Capture of an early fusion-active conformation of HIV-1 gp41 , 1998, Nature Structural Biology.

[15]  Q. Sattentau,et al.  Inhibition of Virus Attachment to CD4+ Target Cells Is a Major Mechanism of T Cell Line–adapted HIV-1 Neutralization , 1997, The Journal of experimental medicine.

[16]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[17]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[18]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[19]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[20]  T. Wolfsberg,et al.  Virus-cell and cell-cell fusion. , 1996, Annual review of cell and developmental biology.

[21]  S. Günther,et al.  Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1 , 1995, Journal of virology.

[22]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[23]  Judith M. White,et al.  Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion , 1994, Cell.

[24]  A. Helenius,et al.  On the entry of semliki forest virus into BHK-21 cells , 1980, The Journal of cell biology.